18 March 2024
CEL AI plc
("Cel AI" or the "Company")
Director's Dealings
Cel AI (LSE: CLAI) announces that it has been notified of the following transactions in ordinary shares in the Company undertaken by directors/persons discharging managerial responsibility (PDMRs), details of which are set out in the notification below.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||||
| a) | Name | Matthew Lodge | ||||||||||
| 2. | Reason for the Notification | |||||||||||
| a) | Position/status | Director | ||||||||||
| b) | Initial notification / Amendment | Initial notification | ||||||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||
| a) | Name | Cel AI plc | ||||||||||
| b) | LEI | 213800IXPX4Z2MKX2U28 | ||||||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares | ||||||||||
| | Identification Code | GB00BK964W87 | ||||||||||
| b) | Nature of the transaction | Sale of Ordinary Shares | ||||||||||
| c) | Price(s) and volume(s) |
| ||||||||||
| d) | Aggregated information: · Aggregated volume · Price |
13,000,000 £53,736 | ||||||||||
| e) | Date of the transaction | 29 February, 06 March, 07 March and 08 March 2024 | ||||||||||
| f) | Place of the Transaction | London Stock Exchange | ||||||||||
For further information please contact:
| Cellular Goods | |
| Michael Edwards Director | via FSCF +44 7572 873 300 |
| First Sentinel Corporate Finance (FSCF) | |
| Investor Relations Rebecca Noonan Media Relations Rebecca Noonan Corporate Broker & Advisor Brian Stockbridge |
+44 7572 873 300
+44 7572 873 300
+44 7858 888 007 |
| Novum Securities |
|
| Corporate Broker Colin Rowbury Jon Belliss |
+44 207 399 9427 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
